Publications by authors named "Sue Hranilovic"
Background: Feminizing hormone therapy (FHT) is essential to many trans women. Concern about negative drug interactions between FHT and ART can be an ART adherence barrier among trans women with HIV.
Objectives: In this single-centre, parallel group, cross-sectional pilot study, we measured serum oestradiol concentrations in trans women with HIV taking FHT and unboosted integrase strand transfer inhibitor (INSTI)-based ART versus trans women without HIV taking FHT.
Article Synopsis
- HIV prevalence among trans women in Canada shows 7.5% are HIV positive, with significant gaps in HIV status data, as 38.1% had missing information.
- Factors associated with higher HIV rates include being Black, an immigrant or refugee, receiving social assistance, and a history of recreational drug use.
- The study emphasizes the need for better HIV testing and support tailored to the unique socioeconomic challenges faced by trans women in Canada.*
Objective: To compare rates of cervical, breast, and colorectal cancer screening between patients who are transgender and those who are cisgender (ie, nontransgender).
Design: Cross-sectional study.
Setting: A multisite academic family health team in Toronto, Ont, serving more than 45 000 enrolled patients.